about
Cyclophilin and NS5A inhibitors, but not other anti-hepatitis C virus (HCV) agents, preclude HCV-mediated formation of double-membrane-vesicle viral factoriesResistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy.Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapy.
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Efficacy of daclatasvir in hepatitis C virus.
@en
type
label
Efficacy of daclatasvir in hepatitis C virus.
@en
prefLabel
Efficacy of daclatasvir in hepatitis C virus.
@en
P2860
P1476
Efficacy of daclatasvir in hepatitis C virus.
@en
P2093
Namiki Izumi
P2860
P304
P356
10.1586/14787210.2014.942282
P577
2014-07-25T00:00:00Z